A detailed history of First Personal Financial Services transactions in Eli Lilly & CO stock. As of the latest transaction made, First Personal Financial Services holds 241 shares of LLY stock, worth $199,967. This represents 0.05% of its overall portfolio holdings.

Number of Shares
241
Previous 241 -0.0%
Holding current value
$199,967
Previous $187,000 16.58%
% of portfolio
0.05%
Previous 0.04%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$592.2 - $792.28 $29,610 - $39,614
-50 Reduced 17.18%
241 $187,000
Q4 2023

Jan 29, 2024

SELL
$525.19 - $619.13 $525 - $619
-1 Reduced 0.34%
291 $169,000
Q2 2023

Jul 28, 2023

BUY
$350.74 - $468.98 $350 - $468
1 Added 0.34%
292 $136,000
Q1 2023

Apr 24, 2023

SELL
$310.63 - $364.82 $10,872 - $12,768
-35 Reduced 10.74%
291 $99,000
Q4 2022

Jan 27, 2023

SELL
$321.55 - $374.67 $9,646 - $11,240
-30 Reduced 8.43%
326 $0
Q3 2022

Oct 27, 2022

BUY
$296.48 - $337.87 $7,412 - $8,446
25 Added 7.55%
356 $115,000
Q1 2022

May 02, 2022

SELL
$234.69 - $291.66 $16,897 - $20,999
-72 Reduced 17.87%
331 $95,000
Q4 2021

Feb 04, 2022

SELL
$224.85 - $279.04 $219,903 - $272,901
-978 Reduced 70.82%
403 $111,000
Q3 2021

Nov 04, 2021

SELL
$221.6 - $272.71 $17,949 - $22,089
-81 Reduced 5.54%
1,381 $319,000
Q2 2021

Aug 02, 2021

SELL
$180.55 - $233.54 $29,429 - $38,067
-163 Reduced 10.03%
1,462 $336,000
Q1 2020

Apr 22, 2020

SELL
$119.05 - $147.35 $17,857 - $22,102
-150 Reduced 8.45%
1,625 $225,000
Q4 2019

Jan 24, 2020

SELL
$106.92 - $132.43 $264,627 - $327,764
-2,475 Reduced 58.24%
1,775 $233,000
Q3 2019

Oct 15, 2019

BUY
$106.79 - $116.16 $23,600 - $25,671
221 Added 5.49%
4,250 $475,000
Q2 2019

Jul 29, 2019

BUY
$110.79 - $129.32 $10,857 - $12,673
98 Added 2.49%
4,029 $446,000
Q4 2018

Jan 30, 2019

BUY
$105.9 - $118.64 $9,425 - $10,558
89 Added 2.32%
3,931 $455,000
Q3 2018

Nov 01, 2018

BUY
$85.86 - $107.31 $8,929 - $11,160
104 Added 2.78%
3,842 $412,000
Q2 2018

Aug 07, 2018

SELL
$75.7 - $86.88 $20,590 - $23,631
-272 Reduced 6.78%
3,738 $319,000
Q1 2018

May 10, 2018

SELL
$74.21 - $87.6 $123,708 - $146,029
-1,667 Reduced 29.36%
4,010 $310,000
Q4 2017

Jan 25, 2018

SELL
$81.94 - $87.89 $86,200 - $92,460
-1,052 Reduced 15.63%
5,677 $479,000
Q3 2017

Nov 01, 2017

BUY
$77.07 - $85.54 $518,604 - $575,598
6,729
6,729 $576,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $788B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track First Personal Financial Services Portfolio

Follow First Personal Financial Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Personal Financial Services, based on Form 13F filings with the SEC.

News

Stay updated on First Personal Financial Services with notifications on news.